Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting intervention description across studies assessing the impact of clinical pharmacy activities.|
|Full bibliographic reference||Rotta I, Salgado TM, Felix DC, Souza TT, Correr CJ, Fernandez-Llimos F. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015;21(4):584-590.|
|Reporting guideline acronym||DEPICT 2|
|Study design||Clinical trials, Experimental studies|
|Clinical area||Pharmaceutical medicine|
|Applies to the whole report or to individual sections of the report?||Intervention (exposure)|
|Previous versions of this guideline / Guideline history||An earlier version of this reporting guideline was published in 2013:
Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013;47(7-8):946-952. PMID: 23757389
|Record last updated on||March 4, 2016|
|Clinical practice guidelines||AGREE||RIGHT|
|Animal pre-clinical studies||ARRIVE|
|Quality improvement studies||SQUIRE|
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.